Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.49.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
V.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.149ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used